1.
Niraula S, Pond G, de Wit R, Eisenberger M, Tannock IF, Joshua AM. Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study. CUAJ [Internet]. 2013 Feb. 20 [cited 2024 Apr. 16];7(1-2):E74-81. Available from: https://cuaj.ca/index.php/journal/article/view/267